b+pharma Belgium SA
b+pharma Belgium reported total assets of €2.39m at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Jun 2026).
The score of b+pharma Belgium shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +40 % Total assets +16 %
Accounts of the company itself (not consolidated).
The full file covers 15 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
b+pharma Belgium's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Jun 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 31 May 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 19 May 2022
b+pharma Belgium's financial analysis
- Solvency90.1%sector median: 45.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of b+pharma Belgium
b+pharma Belgium's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0474.817.869
- VAT number
- BE0474817869
- Peppol
- Registered · 0208:0474817869 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 22 May 2001
- Registered office
- 9051 Ghent
- Latest accounts
- 2025 · filed on 04 Jun 2026
- Activity
- Activities of agents involved in the wholesale of other particular products (NACE 46180)
b+pharma Belgium (SA) has been based in Ghent since 2001, active in: activities of agents involved in the wholesale of other particular products. For 2025, it reports a net profit of 213,458 € and equity of €2.15m; its revenue is not published. Its solvency stands at 90.1%, above the median of its sector (45.3%).
Companies similar to b+pharma Belgium
Companies in the same business, of comparable size and area, outside its group.
- Bygalamart Activities of agents involved in the wholesale of other particular products Antwerp · balance sheet 10,714 €
- VM Distribution Activities of agents involved in the wholesale of other particular products Waterloo · balance sheet 31 €
- HERA Activities of agents involved in the wholesale of other particular products Houyet · balance sheet 70,358 €
- Haluson Activities of agents involved in the wholesale of other particular products La Bruyère · balance sheet €2.78m
- BSA Pharmaceuticals Activities of agents involved in the wholesale of other particular products Brussels · balance sheet 117,380 €
- Steyaert Bart Activities of agents involved in the wholesale of other particular products Staden · balance sheet €2.79m
- Nordic Baking & Cooking Activities of agents involved in the wholesale of other particular products Wetteren · balance sheet €1.69m
- Kelvin Invest Activities of agents involved in the wholesale of other particular products Ledegem · balance sheet €1.40m
Frequently asked questions about b+pharma Belgium
What is the revenue of b+pharma Belgium?
b+pharma Belgium files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of b+pharma Belgium?
In Belgium, the VAT number is the company number prefixed with BE: BE0474817869 for b+pharma Belgium, if the company is VAT-registered. Its company number (CBE) is 0474.817.869.
Where is the registered office of b+pharma Belgium?
According to the CBE register, the registered office of b+pharma Belgium is in 9051 Ghent.
What is the equity of b+pharma Belgium?
At the close of the 2025 financial year, the equity of b+pharma Belgium amounts to 2,154,764 €, a solvency of 90.1% of total assets.
Who manages b+pharma Belgium?
The register lists 4 active mandates at b+pharma Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of b+pharma Belgium
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →